Literature DB >> 23452574

Isolated cortical vein thrombosis: a rare cause of venous stroke with good prognosis after timely diagnosis and treatment.

José E Cohen1, Michaela Duck, John M Gomori, Eyal Itshayek, Ronen R Leker.   

Abstract

BACKGROUND: Isolated cortical vein thrombosis (ICoVT) is a rare condition representing approximately 6% of cerebral vein thromboses (CVT). In all its forms, CVT is more prevalent in women. ICoVT shares the same group of predisposing conditions typical of other CVT. It may thus be easily missed due to its non-specific clinical presentation and confounding radiological findings, which may lead to a delay in appropriate diagnosis and treatment.
METHODS: A comprehensive literature search was conducted to identify manuscripts discussing epidemiology, risk factors, clinical presentation, radiological techniques and presentation, management, and outcome in patients with ICoVT.
RESULTS: We identified 40 papers published between 1991 and 2012 that met our criteria for review. DISCUSSION: MR techniques are essential in the diagnosis of this entity. Without appropriate therapy, these thromboses may extend bidirectionally and even compromise the dural sinuses. Correction of predisposing factors for venous thrombosis and anticoagulation is the therapy of choice for most patients. The overall prognosis with adequate and timely therapy is very good.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23452574     DOI: 10.1179/1743132812Y.0000000148

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  2 in total

1.  Not just another thunderclap headache: a case of isolated cortical vein thrombosis and subarachnoid haemorrhage.

Authors:  Edith Vassallo; Christine Azzopardi; Reuben Grech
Journal:  BMJ Case Rep       Date:  2015-11-12

2.  Pathological confirmation of 4 cases with isolated cortical vein thrombosis previously misdiagnosed as brain tumor.

Authors:  Yingxin Yu; Ming Ren; Sheng Yao; Xiongfei Zhao; Xiaokun Qi
Journal:  Oncol Lett       Date:  2015-11-17       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.